0.98
-16.57%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Trxade Group
From its filings with the US Securities and Exchange Commission
Trxade Group is based in Tampa, Florida and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker MEDS. The SEC classifies its business as wholesale-drugs, proprietaries & druggists' sundries. In the fiscal year to 31 December 2025, it reported revenue of $23.3m and a net loss of $101.3m. At that date it held total assets of $30.5m and shareholders' equity of −$12.4m.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 27 Apr 2010
- Website
- trxadehealth.com ↗
- Head office
- 3000 BAYPORT DRIVE SUITE 950, TAMPA, FL, 33607
- Incorporated in
- DE
- Classification
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Mr. Surendra AjjarapuChairman of the Board, Chief Executive Officer, Secretary, since 2014$430,878
- Mr. Prashant PatelPresident, Interim Chief Financial Officer, Chief Operating Officer, Interim Chief Accounting Officer, Director, since 2014$157,038
- Ms. Candice BeaumontDirector
- Mr. Donald FellIndependent Director$129,250
- Mr. Jeff NewellIndependent Director$59,350
- Mr. Michael PetersonIndependent Director$96,250
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Trxade Group Inc has a strong reputation in the pharmaceutical industry, with years of experience and a solid client base.
- The company has developed advanced technology platforms that have allowed them to streamline their operations and improve efficiency.
- Trxade Group Inc has a diverse product portfolio, offering a wide range of pharmaceuticals to meet the needs of different customers.
Weaknesses
- Trxade Group Inc is heavily reliant on third-party suppliers for their pharmaceutical products, which could be a vulnerability if those suppliers face any issues.
- The company operates within a highly regulated industry, which means they must comply with strict rules and regulations, potentially adding complexity and costs to their operations.
- Trxade Group Inc may lack brand recognition compared to some of their larger competitors in the market.
Opportunities
- The growing demand for affordable and accessible pharmaceuticals presents an opportunity for Trxade Group Inc to expand their customer base.
- The company could leverage their advanced technology platforms to offer innovative solutions, such as improving supply chain management or enhancing customer experience.
- Trxade Group Inc could explore strategic partnerships or acquisitions to expand their market presence and diversify their product offerings.
Threats
- The pharmaceutical industry is highly competitive, with the presence of established players and potential new entrants, posing a threat to Trxade Group Inc's market share.
- Changes in government regulations or policies could impact the operations and profitability of Trxade Group Inc.
- The ongoing COVID-19 pandemic and its potential long-term effects could disrupt supply chains and affect customer demand for pharmaceutical products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.